We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$270M
AUM Growth
-$91.5M
Cap. Flow
-$47.5M
Cap. Flow %
-17.6%
Top 10 Hldgs %
29.27%
Holding
186
New
6
Increased
34
Reduced
74
Closed
23

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$7.06M
2
UNH icon
UnitedHealth
UNH
+$6.09M
3
ZTS icon
Zoetis
ZTS
+$5.52M
4
ULTA icon
Ulta Beauty
ULTA
+$3.73M
5
VZ icon
Verizon
VZ
+$479K

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$7.85M
2
PSX icon
Phillips 66
PSX
+$7.78M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.68M
4
SCHW
Charles Schwab
SCHW
+$7.42M
5
CTAS icon
Cintas
CTAS
+$7.25M

Sector Composition

Rank Sector Weight
1 Healthcare 24.65%
2 Technology 17.48%
3 Financials 9.53%
4 Industrials 8.75%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ED icon
26
Consolidated Edison
ED
$40.2B
$3.2M 1.19%
41,891
-839
-2% -$65.6K
VZ icon
27
Verizon
VZ
$195B
$3.17M 1.17%
56,351
+8,441
+18% +$479K
BMY icon
28
Bristol-Myers Squibb
BMY
$131B
$3.15M 1.17%
60,646
-1,495
-2% -$80.3K
LLY icon
29
Eli Lilly
LLY
$1.06T
$3.01M 1.12%
26,035
– –
PEP icon
30
PepsiCo
PEP
$189B
$2.89M 1.07%
26,127
+350
+1% +$39.5K
ICUI icon
31
ICU Medical
ICUI
$4.16B
$2.85M 1.06%
12,430
-840
-6% -$207K
SO icon
32
Southern Company
SO
$107B
$2.73M 1.01%
62,069
-770
-1% -$35K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.13T
$2.65M 0.98%
13,005
-150
-1% -$31.3K
D icon
34
Dominion Energy
D
$58.8B
$2.48M 0.92%
34,702
+5
+0% +$365
RGCO icon
35
RGC Resources
RGCO
$228M
$2.41M 0.89%
80,577
– –
TFC icon
36
Truist Financial
TFC
$64.2B
$2.4M 0.89%
55,333
-1,265
-2% -$60.7K
INTC icon
37
Intel
INTC
$503B
$2.31M 0.86%
49,271
-260
-0.5% -$12.2K
SUPN icon
38
Supernus Pharmaceuticals
SUPN
$2.72B
$2.08M 0.77%
62,680
-25,835
-29% -$1.11M
VWO icon
39
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$1.98M 0.73%
51,844
-4,200
-7% -$163K
NFLX icon
40
Netflix
NFLX
$307B
$1.94M 0.72%
72,600
– –
CVX icon
41
Chevron
CVX
$371B
$1.93M 0.71%
17,738
-97
-0.5% -$11.2K
DD icon
42
DuPont de Nemours
DD
$19.5B
$1.89M 0.7%
13,931
-582
-4% -$83.6K
DUK icon
43
Duke Energy
DUK
$96.6B
$1.81M 0.67%
20,986
+1,150
+6% +$97.9K
T icon
44
AT&T
T
$162B
$1.81M 0.67%
83,983
-16,023
-16% -$373K
TRV icon
45
Travelers Companies
TRV
$80.5B
$1.71M 0.63%
14,301
-595
-4% -$74.5K
AGN
46
DELISTED
Allergan plc
AGN
$1.7M 0.63%
12,710
+125
+1% +$20.5K
JPC icon
47
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$1.69M 0.63%
202,650
-23,000
-10% -$203K
OKE icon
48
Oneok
OKE
$55.4B
$1.65M 0.61%
30,617
-350
-1% -$21.7K
MRK icon
49
Merck
MRK
$317B
$1.58M 0.59%
21,710
-176
-0.8% -$12.4K
AMZN icon
50
Amazon
AMZN
$2.94T
$1.54M 0.57%
20,560
+2,300
+13% +$191K
1
2
3 4 5

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q4 2018 Portfolio in Review

As of Q4 2018, Dixon Hubard Feinour & Brown held 186 positions worth $270M, down 25% from $362M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Dixon Hubard Feinour & Brown withdrew a net $47.5M in Q4 2018, closing 23 positions and reducing 74 holdings. Its most notable exit was Amphenol, an estimated $7.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Dixon Hubard Feinour & Brown opened a new position in Edwards Lifesciences worth $7.12M.

  • Dixon Hubard Feinour & Brown's largest Q4 2018 buy was Edwards Lifesciences: 139,536 shares worth $7.12M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q4 2018, an estimated $6.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $7.68M.
  • Dixon Hubard Feinour & Brown fully exited Amphenol in Q4 2018, selling an estimated $7.85M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 29% of its $270M portfolio in Q4 2018.
  • Dixon Hubard Feinour & Brown opened 6 new positions and closed 23 in Q4 2018.
  • Dixon Hubard Feinour & Brown's portfolio value fell 25% quarter-over-quarter to $270M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2018, filed 13 Feb 2019.